Skip to content
Search

Latest Stories

Submit Guest Post

ICICI Bank launches UPI facility for NRIs in India

According to the statement, the ICICI Bank has made this service available through its mobile banking app, iMobile Pay.

ICICI Bank launches UPI facility for NRIs in India

ICICI Bank has introduced Unified Payments Interface (UPI) payments for its non-resident Indian (NRI) customers in India, using their international mobile numbers.

This move aims to enhance the convenience of everyday payments for NRIs.


UPI is an instant real-time payments system that enables users to transfer money across multiple banks without disclosing bank account details, offering options using phone numbers and QR codes.

"With this facility, the NRI customers of the bank can make payments for their utility bills, merchant, and e-commerce transactions with their international mobile number registered with their NRE/NRO bank account held with ICICI Bank in India," a statement released by the bank said.

According to the statement, the bank has made this service available through its mobile banking app, iMobile Pay.

Previously, NRIs had to register an Indian mobile number with their bank accounts to make UPI payments across 10 countries, namely, the USA, UK, UAE, Canada, Singapore, Australia, Hong Kong, Oman, Qatar, and Saudi Arabia.

NRI customers of the bank can make UPI payments by scanning any Indian QR code, send money to a UPI ID, or any Indian mobile number or Indian bank account.

"With this facility, our NRI customers residing in 10 countries do not need to switch to an Indian mobile number to pay using UPI," Sidharatha Mishra, Head – Digital Channels and Partnerships, ICICI Bank, said.

According to him, with this initiative, the bank intends to leverage NPCI's UPI (Unified Payments Interface) infrastructure in "strengthening and transforming the digital payments ecosystem globally".

(PTI)

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

AstraZeneca

AstraZeneca chief executive Pascal Soriot says the company has the science, pipeline and team to deliver its long-term growth ambitions

Getty Images

AstraZeneca targets $80bn revenue by 2030 with $1.5bn savings and pipeline investment

  • AstraZeneca expects its restructuring programme to generate $1.5bn in annualised savings by 2029, with most of the money reinvested in research and development.
  • The plan could incur up to $2bn in one-off restructuring costs, although the company expects its overall workforce to continue growing.
  • Third-quarter revenue rose 7 per cent to $16.21bn, while oncology sales increased 17 per cent to $7.77bn.

AstraZeneca has unveiled plans to generate around $1.5bn in annual savings through a three-year restructuring programme, as chief executive Pascal Soriot shifts the focus back to growth and investment in its drug pipeline.

The British-based pharmaceutical group said its Reshaping for Sustainable Growth programme would redirect resources towards research and development, particularly its pipeline of more than 180 projects and emerging technologies.

Keep ReadingShow less